-
Mashup Score: 18A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA - 2 month(s) ago
High-risk, untreated transplant-associated thrombotic microangiopathy after HCT has a dismal outcome due to multi-organ dysfunction.Early therapy with the C5 bl
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7
After scoring an FDA nod Monday for the first gene therapy to treat the rare genetic disease metachromatic leukodystrophy (MLD) in the U.S., Kyowa Kirin and its subsidiary Orchard Therapeutics have | After scoring an FDA nod Monday for the first gene therapy to treat the rare genetic disease metachromatic leukodystrophy in the U.S., Kyowa Kirin and its subsidiary Orchard Therapeutics have broken new boundaries in pricing, too.
Source: www.fiercepharma.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12
Patients with a TRiP(cast) score of less than 7 who are not receiving anticoagulation have a very low risk of venous thromboembolism. A large proportion of patients with lower limb trauma and immobilisation could safely avoid thromboprophylaxis.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32
Original Article from The New England Journal of Medicine — Microplastics and Nanoplastics in Atheromas and Cardiovascular Events
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
Plastics are not harming just sea animals. 150 of 304 (58%) of patients were found to have microplastics and nanoplastics (MNP) in carotic atheroma! Patients with MNP were more likely to have a heart attack, stroke or to die. Paper in this week's @NEJM. https://t.co/R5wSOpRpR3 https://t.co/932EetLo82
-
-
Mashup Score: 30
Original Article from The New England Journal of Medicine — Microplastics and Nanoplastics in Atheromas and Cardiovascular Events
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
Plastics are not harming just sea animals. 150 of 304 (58%) of patients were found to have microplastics and nanoplastics (MNP) in carotic atheroma! Patients with MNP were more likely to have a heart attack, stroke or to die. Paper in this week's @NEJM. https://t.co/R5wSOpRpR3 https://t.co/932EetLo82
-
-
Mashup Score: 9CSL Behring Signs First Commercial Agreement in Austria to Fund Haemophilia B Gene Therapy HEMGENIX® (1) - 2 month(s) ago
Global biotechnology leader CSL Behring (ASX: CSL) today announced that a commercial contract has been signed to fund HEMGENIX® (etranacogene dezaparvovec) in Austria, with the option to access a dedicated fund, established by the provinces for specialised medicines. This is the first commercial …
Source: www.pharmiweb.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 104How I diagnose and treat antiphospholipid syndrome in pregnancy - 2 month(s) ago
Edited by Associate Editor Thomas Ortel, this How I Treat series on hematologic complications of pregnancy uses illustrative cases to discuss the management of
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 100How I diagnose and treat antiphospholipid syndrome in pregnancy - 2 month(s) ago
Edited by Associate Editor Thomas Ortel, this How I Treat series on hematologic complications of pregnancy uses illustrative cases to discuss the management of
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 69How I treat thrombocytopenia in pregnancy - 2 month(s) ago
Edited by Associate Editor Thomas Ortel, this How I Treat series on hematologic complications of pregnancy uses illustrative cases to discuss the management of
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17Breaking ground in haemophilia B gene therapy: insights from the HOPE-B trial and beyond - 2 month(s) ago
There are more references available in the full text version of this
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
Not an RCT, but encouraging data suggesting that Eculizumab may have a role in the treatment of high risk stem cell transplant associated thrombotic microangiopathy. Paper in @BloodJournal but PDF behind paywall. https://t.co/2DQKAGNEWN https://t.co/spDqnuP514